Bullboard - Stock Discussion Forum Harmony Biosciences Holdings Inc HRMY

Healthcare

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company. It is focused on developing and commercializing therapies for patients living with rare neurological diseases as well as patients living with other neurological diseases who have unmet medical needs. Its product, WAKIX (pitolisant), is a first-in-class molecule with a novel mechanism of action designed to enhance... see more

Add To Watchlist

NDAQ:HRMY - Post Discussion

Harmony Biosciences Holdings Inc > PITOLISANT IS A “PORTFOLIO IN A PRODUCT” OPPORTUNITY!

View:

Post by AviseAnalytics on Jun 02, 2022 7:51am

PITOLISANT IS A “PORTFOLIO IN A PRODUCT” OPPORTUNITY!

Harmony Biosciences, Inc. (NASDAQ: HRMY) is a commercial-stage biopharmaceutical company developing novel therapeutics for rare and orphan diseases, focusing on central nervous system disorders. Pitolisant, its lead product candidate, is a first-in-class histamine 3 (H3) receptor antagonist/inverse agonist that can help treat excessive daytime sleepiness (EDS), narcolepsy, and cataplexy.

We take a look at what's in the pipeline for Harmony Biosciences!

Read on to know more:

https://www.aviseanalytics.com/pitolisant-is-a-portfolio-in-a-product-opportunity/

118